Spike Medicine 22
  • Home

  • About Us

      • Company Profile

      • Enterprise culture

      • Qualification Honor

      • Chairman's Speech

  • News

      • Company Dynamics

      • Industry dynamics

  • Recruitment

  • Contact Us

      • Contact Information

      • Online message

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

+86-579-82131973
中文
NEWS

Dec 02,2016

Zhejiang Jianfeng Pharmaceutical Co., Ltd. VOC Pollution Remediation Information Publicity


Key words:

Zhejiang Jianfeng Pharmaceutical Co., Ltd. VOC Pollution Remediation Information Publicity

Dec 08,2016

The General Administration reminds the public to be aware of the risk of liver injury caused by Xianlinggubao oral preparation.


The General Administration reminds the public to be aware of the risk of liver injury caused by Xianlinggubao oral preparation.

Key words:

The General Administration reminds the public to be aware of the risk of liver injury caused by Xianlinggubao oral preparation.

Dec 19,2016

In November 2016, the General Administration approved the listing of 20 drugs.


In November 2016, the General Administration approved the listing of 20 drugs.

Key words:

In November 2016, the General Administration approved the listing of 20 drugs.

Dec 21,2016

The General Office of the General Administration openly solicits opinions on guiding principles such as on-site verification of quality and efficacy consistency evaluation studies of generic drugs.


The General Office of the General Administration openly solicits opinions on guiding principles such as on-site verification of quality and efficacy consistency evaluation studies of generic drugs.

Key words:

The General Office of the General Administration openly solicits opinions on guiding principles such as on-site verification of quality and efficacy consistency evaluation studies of generic drugs.

Dec 30,2016

General Directorate reminds public of cardiovascular risks caused by testosterone drugs


General Directorate reminds public of cardiovascular risks caused by testosterone drugs

Key words:

General Directorate reminds public of cardiovascular risks caused by testosterone drugs

Dec 30,2016

How to spread R & D risk? New drug layout four logic N tips


How to spread R & D risk? New drug layout four logic N tips

Key words:

How to spread R & D risk? New drug layout four logic N tips
< 1...575859...162 >
contact Contact
tel +86-579-82131973
tel gs@zjifyy.com.cn
Whatsapp
top TOP
Chenglian Medicine

Follow us

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息: JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page